Company intelligence / Profile preview

Oxford Bioscience Partners

Boston, Massachusetts, United Stateslife-sciences-usa.com ↗

Ownership: Private
Development stage: Other

Overview

Oxford Bioscience Partners was a prominent venture capital firm specializing in early-stage investments in life sciences, biotechnology, healthcare technology, and related sectors. The general partners managed over $800 million in committed capital and played key roles on the boards of more than 50 companies. The firm's last known fund activity was around the early-to-mid 2010s, and it is now generally considered inactive.

Industry: Investors

Partnerships

Evotec SE (collaboration on drug discovery platform EVOrational)

Beyond the preview

Go deeper on Oxford Bioscience Partners.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Oxford Bioscience Partners.

Explore the full profile